- Home
- XTNT vs PMVP Comparison
XTNT vs PMVP Comparison
Compare XTNT & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- PMVP
- Stock Information
- Founded
- XTNT N/A
- PMVP 2013
- Country
- XTNT United States
- PMVP United States
- Employees
- XTNT N/A
- PMVP N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- XTNT Health Care
- PMVP Health Care
- Exchange
- XTNT Nasdaq
- PMVP Nasdaq
- Market Cap
- XTNT 60.9M
- PMVP 62.3M
- IPO Year
- XTNT N/A
- PMVP 2020
- Fundamental
- Price
- XTNT $0.65
- PMVP $1.34
- Analyst Decision
- XTNT
- PMVP Strong Buy
- Analyst Count
- XTNT 0
- PMVP 1
- Target Price
- XTNT N/A
- PMVP $5.00
- AVG Volume (30 Days)
- XTNT 86.4K
- PMVP 239.6K
- Earning Date
- XTNT 08-07-2025
- PMVP 08-07-2025
- Dividend Yield
- XTNT N/A
- PMVP N/A
- EPS Growth
- XTNT N/A
- PMVP N/A
- EPS
- XTNT N/A
- PMVP N/A
- Revenue
- XTNT $122,298,000.00
- PMVP N/A
- Revenue This Year
- XTNT $11.64
- PMVP N/A
- Revenue Next Year
- XTNT $7.59
- PMVP N/A
- P/E Ratio
- XTNT N/A
- PMVP N/A
- Revenue Growth
- XTNT 20.81
- PMVP N/A
- 52 Week Low
- XTNT $0.33
- PMVP $0.81
- 52 Week High
- XTNT $0.83
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- XTNT 48.08
- PMVP 72.39
- Support Level
- XTNT $0.60
- PMVP $0.96
- Resistance Level
- XTNT $0.78
- PMVP $1.36
- Average True Range (ATR)
- XTNT 0.05
- PMVP 0.09
- MACD
- XTNT -0.00
- PMVP 0.02
- Stochastic Oscillator
- XTNT 26.37
- PMVP 95.31
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.